India's Hester Biosciences gains on plan to sell stake in Texas Lifesciences

Hester Biosciences

11/03/2026 07:03

** Hester Biosciences HEST.NS rises 3.9% to 1,501.30 rupees; set to snap seven session losing streak

** Pharmaceuticals co to divest 43.81% of total 54.81% stake in subsidiary Texas Lifesciences for 92 mln rupees ($1 mln)

** Says it will continue to do business with Texas Lifesciences and maintain 11% stake

** Trading vols ~2x the 30-day average

** HEST down ~6% YTD

($1 = 91.9100 Indian rupees)

 (Reporting by Vijay Malkar)

 ((VijayDattaram.Malkar@thomsonreuters.com;))